WebFind the latest Curis, Inc. (CRIS) stock quote, history, news and other vital information to help you with your stock trading and investing. WebMar 2, 2024 · Curis stock soars 34% as FDA lifts partial clinical hold on emavusertib's lymphoma study SA News Thu, Aug. 18, 2024 Curis GAAP EPS of -$0.17 in-line, revenue of $2.39M misses by $0.33M
Curis Inc. Inc. (CRIS) Price Performance: A Fundamental Analysis ...
WebAug 30, 2024 · Nasdaq provides updated worldwide news headlines. Here you can find up-to-the-minute news and analysis of the company that you are researching for potential … WebAt Curis, we are developing differentiated therapeutics with the goal of improving the lives of cancer patients. Our new animation shows how Emavusertib (CA-4948) is being developed to target hematologic … bin to mp3 up to 200 mb
Curis, Inc. (CRIS) Latest Stock News & Headlines - Yahoo!
WebApr 13, 2024 · Curis Inc. (NASDAQ:CRIS) shares, rose in value on Wednesday, 04/12/23, with the stock price up by 9.26% to the previous day’s close as strong demand from buyers drove the stock to $0.83. Actively observing the price movement in the last trading, the stock closed the session at $0.76, falling within a range of $0.73 and $0.849. WebThe Curis stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund … WebApr 12, 2024 · The price of CRIS fallen by 21.30% during the last 30 days period. For the last 5-days stocks have improved 33.75%. The present stock price for Curis Inc. (CRIS) is $0.76. In the last trading session, the stock made a considerable jump, reaching $0.7694 after an opening price of $0.64. binton church facts